As of 2026-09-19, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -67.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,700.76 mil USD. TNDM's TTM EBITDA according to its financial statements is -25.03 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 12.1x | 10.2x |
| Forward P/E multiples | 11.0x - 14.6x | 12.7x |
| Fair Price | (11.95) - (12.38) | (12.12) |
| Upside | -170.8% - -173.4% | -171.9% |
| Date | EV/EBITDA |
| 2026-09-17 | -68.93 |
| 2026-09-16 | -69.75 |
| 2026-09-15 | -66.33 |
| 2026-09-14 | -67.78 |
| 2026-09-11 | -68.60 |
| 2026-09-10 | -71.88 |
| 2026-09-09 | -74.07 |
| 2026-09-08 | -76.18 |
| 2026-09-04 | -76.24 |
| 2026-09-03 | -77.69 |
| 2026-09-02 | -78.04 |
| 2026-09-01 | -80.01 |
| 2026-08-31 | -82.01 |
| 2026-08-28 | -80.42 |
| 2026-08-27 | -80.34 |
| 2026-08-26 | -80.26 |
| 2026-08-25 | -80.83 |
| 2026-08-24 | -82.59 |
| 2026-08-21 | -82.86 |
| 2026-08-20 | -83.54 |
| 2026-08-19 | -85.98 |
| 2026-08-18 | -86.72 |
| 2026-08-17 | -82.68 |
| 2026-08-14 | -83.96 |
| 2026-08-13 | -85.08 |
| 2026-08-12 | -85.93 |
| 2026-08-11 | -85.93 |
| 2026-08-10 | -84.20 |
| 2026-08-07 | -83.02 |
| 2026-08-06 | -73.20 |
| 2026-08-05 | -75.39 |
| 2026-08-04 | -77.06 |
| 2026-08-03 | -76.81 |
| 2026-07-31 | -75.14 |
| 2026-07-30 | -73.80 |
| 2026-07-29 | -72.65 |
| 2026-07-28 | -70.38 |
| 2026-07-27 | -68.76 |
| 2026-07-24 | -68.63 |
| 2026-07-23 | -68.02 |
| 2026-07-22 | -68.05 |
| 2026-07-21 | -69.94 |
| 2026-07-20 | -71.31 |
| 2026-07-17 | -68.52 |
| 2026-07-16 | -66.35 |
| 2026-07-15 | -63.59 |
| 2026-07-14 | -64.30 |
| 2026-07-13 | -66.24 |
| 2026-07-10 | -63.94 |
| 2026-07-09 | -63.83 |